The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.55
Bid: 1.50
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.10 (6.667%)
Open: 1.55
High: 1.55
Low: 1.55
Prev. Close: 1.55
STX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Comptoir opens restaurant; Intercede wins contract

Thu, 07th Dec 2023 15:31

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

----------

Comptoir Group PLC - Owner and operator of a chain of Lebanese restaurants - Opens new restaurant at the Southbank Centre, London. The restaurant will be located opposite the entrance of the Royal Festival Hall, neighbouring Las Iguanas, Cote Brasserie and Honest Burgers restaurants. Says that with over 5,400 events a year, the Southbank Centre site has a footfall of 19 million a year. Expects to open restaurant around Easter next year. Chief Executive Nick Ayerst says: "Following the successful recent opening in Ealing, we are pleased to announce the continued strategic growth in an area of London we have long desired to be in. The location on the South Bank captures an immensely high footfall of both workers, visitors and tourists who we know will be hungry for our well-loved authentic Middle Eastern food and culture."

----------

Intercede Group PLC - Lutterworth, England-based cybersecurity software - Wins a professional services order to help deploy MyID Credential Management Solution to "large US Federal Agency." Says it is the same customer which it won a contract with on Tuesday. Says additional order, worth USD800,000, underpins the company's upgraded financial 2024 and 2025 forecasts. "Once again, I am pleased to announce a further order that supports our upgraded forecasts for FY24 and FY25. This is a testament of the hard work my colleagues have done and indeed continue to do so," says CEO Klaas van der Leest. On Tuesday, Intercede said it signed a "major" new contract with the unnamed large US federal agency, with purchase orders received of perpetual licences worth around USD6.6 million. Due to the order, the company expects its financial year 2024 results to be "significantly ahead of market expectations," which it says are a revenue of GBP13.7 million and adjusted earnings before interest, tax, depreciation and amortisation of GBP1.8 million.

----------

Datalex PLC - Dublin-based software company, which specialises in digital retail technology for the airline market - Announces the go live of its Datalex Merchandiser product with easyJet PLC, a Luton Airport-based low-cost airline. Says easyJet is set to begin its migration to Datalex Direct and Datalex Dynamic in 2024 to drive next generation retailing and an improved booking experience. Chief Revenue Officer Bryan Porter says: "We are proud to be partnering with easyJet to drive forward the airline's digital retail strategy, supporting high value revenue growth and enhancing the exceptional customer experience for easyJet's customers. The recent go live is a major milestone in our journey, and we look forward to continuing to provide the airline with superior and innovative digital retailing capabilities that will enable them to deliver new, revenue generating and differentiated customer experiences."

----------

Wynnstay Properties PLC - Powys, Wales-based agricultural and specialist merchanting firm - Exchanges contracts for the acquisition from three members of the Gunne family of Units 1-4, 18a Wildmere Road, Banbury, and Unit 14, The IO Centre, Whittle Way, Stevenage, for GBP2.5 million in total. The Banbury property is freehold and comprises two industrial buildings, separately let to established national and regional trade counter businesses, with service yards and an access road. The total rent passing is GBP103,425 per year. The Stevenage Property is held on a 999-year lease at a nominal rent and comprises a mid-terrace industrial unit. The rent passing on the single occupational sub-lease to an established national trade counter business is GBP57,550 per annum. The acquisition in expected to complete at the beginning of 2024. Chris Betts, Managing Director of Wynnstay, says: "The acquisition of these highly accessible and well-let properties broadens the geographic spread of Wynnstay's portfolio and enhances our focus on the growth potential of the light industrial/trade counter warehouse sector."

----------

Develop North PLC - investor in residential and commercial property sector advised by Newcastle, England-based Tier One Capital Ltd - Extends share buyback programme. Says it will repurchase up to a further GBP500,000. The programme will end December 31. The purchased shares will be held in treasury.

----------

Eqtec PLC - Thermochemical conversion technology company - Signs an equipment supply agreement for engineering services and equipment supply for a plant in Wilseyville, California, US. The plant is being developed to cleanly convert approximately 25,000 tonnes per year of wood waste into synthesis gas to fuel a gas engine coupled to alternators for production of about 3.0 MWe electricity. The Agreement is with Blue Mountain Electric Company LLC, a project company set up and operated by Phoenix Biomass Energy Inc. Expects to commence basic engineering work in early 2024 and to invoice about USD330,000 for this work, which the company expects to complete in the first half of 2024.

----------

Videndum PLC - London-based manufacturer of hardware and software for the content creation market, including broadcasters and film studios - Raises GBP125 million through placing and open offer. Raises GBP75 million through placing of 28.1 million shares and GBP50 million through open offer of 18.7 million shares. CEO Stephen Bird says: "We are pleased with the very strong response to the capital raising and I would like to thank both our shareholders and new investors for their support. We now have a robust capital base which will enable Videndum to focus its resources on strategic execution and long-term value creation for shareholders through our market-leading, premium brands which are focused on the content creation market."

----------

Shield Therapeutics PLC - Commercial-stage pharmaceutical company focusing on its iron deficiency product Accrufer - Updates shareholders on third quarter US commercial highlights. Total prescriptions reach over 27,750, up 76% from the second quarter. Notes US third quarter net revenue of USD4.1 million. CEO Greg Madison comments: "Shield continues to make excellent progress on the US commercial launch of Accrufer. As we approach the one-year anniversary of the announcement of the Viatris agreement, I am pleased to report that the collaboration continues to deliver excellent results, based on the stand-out performance of the combined commercial team, which has produced consistent and strong sequential prescription growth and key performance indicators, which are trending towards previous guidance."

----------

By Sophie Rose, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Sep 2022 20:43

EARNINGS SUMMARY: Open Orphan name change; Secured Income winds down

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
1 Sep 2022 15:59

UK earnings, trading statements calendar - next 7 days

Friday 2 September 
Ashmore Group PLCFull Year Results
Monday 5 September 
Belvoir Group PLCHalf Year Results
Dechra Pharmaceuticals PLCFull Year Results
Tuesday 6 September 
Accrol Group Holdings PLCFull Year Results
Alumasc Group PLCFull Year Results
Ashtead Group PLCQ1 Results
Capricorn Energy PLCHalf Year Results
Gamma Communications PLCHalf Year Results
Headlam Group PLCHalf Year Results
Inspired PLCHalf Year Results
IQE PLCHalf Year Results
Lords Group Trading PLCHalf Year Results
Luceco PLCHalf Year Results
Michelmersh Brick Holdings PLCHalf Year Results
Midwich Group PLCHalf Year Results
NCC Group PLCFull Year Results
PCI-PAL PLCFull Year Results
Pebble Group PLCHalf Year Results
Quixant PLCHalf Year Results
STV Group PLCHalf Year Results
WAG Payment Solutions PLCHalf Year Results
WANdisco PLCHalf Year Results
Wednesday 7 September 
Bakkavor Group PLCHalf Year Results
Barratt Developments PLCFull Year Results
Equals Group PLCHalf Year Results
M Winkworth PLCHalf Year Results
Malin Corp PLCHalf Year Results
Petropavlovsk PLCHalf Year Results
Somero Enterprises IncHalf Year Results
Tissue Regenix Group PLCHalf Year Results
WH Smith PLCTrading Statement
Thursday 8 September 
Arecor Therapeutics PLCHalf Year Results
Cairn Homes PLCHalf Year Results
Curtis Banks Group PLCHalf Year Results
Darktrace PLCFull Year Results
Destiny Pharma PLCHalf Year Results
Duke Royalty LtdFull Year Results
Emis Group PLCHalf Year Results
Energean PLCHalf Year Results
Funding Circle Holdings PLCHalf Year Results
Genus PLCFull Year Results
International Public Partnerships LtdHalf Year Results
Melrose Industries PLCHalf Year Results
Mpac Group PLCHalf Year Results
Oakley Capital Investments LtdHalf Year Results
Open Orphan PLCHalf Year Results
Restaurant Group PLCHalf Year Results
Safestore Holdings PLCQ3 Results
Severfield PLCFull Year Results
Shield Therapeutics PLCHalf Year Results
SourceBio International PLCHalf Year Results
Spire Healthcare Group PLCHalf Year Results
Sylvania Platinum LtdFull Year Results
Vistry Group PLCHalf Year Results
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
1 Aug 2022 19:38

IN BRIEF: Shield Therapeutics to gain USD10 million loan from AOP

Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Existing shareholder AOP Health International Management agrees to loan USD10 million to Shield, which will draw it down in a single tranche, and being secured over Shield's US intellectual property rights.

Read more
20 Jul 2022 16:03

UK shareholder meetings calendar - next 7 days

Thursday 21 July  
Big Yellow Group PLCAGM
Evgen Pharma PLCAGM
Experian PLCAGM
Halma PLCAGM
Intermediate Capital Group PLCAGM
Johnson Matthey PLCAGM
Octopus AIM VCT PLCAGM
Pennon Group PLCAGM
Pires Investments PLCGM re offer from Tern PLC
QinetiQ Group PLCAGM
SSE PLCAGM
Tern PLCGM re offer for Pires Investments PLC
Vp PLCAGM
Workspace Group PLCAGM
Zephyr Energy PLCAGM
Friday 22 July  
Chesterfield Resources PLCAGM
Homeserve PLCGM re offer by affiliates of Brookfield Infrastructure Partners LP
JD Sports Fashion PLCAGM
Landore Resources LtdAGM
President Energy PLCAGM
United Utilities Group PLCAGM
WANdisco PLCAGM
Monday 25 July 
BP Marsh & Partners PLCAGM
Keras Resources PLCAGM
Keras Resources PLCGM re share consolidation
Tuesday 26 July 
AO World PLCAGM
Bytes Technology Group PLCAGM
Dekel Agri-Vision PLCAGM
Firering Strategic Minerals PLCAGM
Mitie Group PLCAGM
Momentum Multi-Asset Value Trust PLCAGM
nanosynth group PLCAGM
NewRiver REIT PLCAGM
Ninety One PLC & LtdAGM
OnTheMarket PLCAGM
OptiBiotix Health PLCAGM
Telecom Plus PLCAGM
Vodafone Group PLCAGM
Xeros Technology Group PLCAGM
Wednesday 27 July 
Allied Minds PLCAGM
Caledonia Investments PLCAGM
De La Rue PLCAGM
FirstGroup PLCAGM
James Cropper PLCAGM
JPMorgan Japan Small Cap Growth & Income PLCAGM
Mode Global Holdings PLCAGM
Montanaro UK Smaller Cos Investment Trust PLCAGM
Motorpoint Group PLCAGM
Shield Therapeutics PLCAGM
Tatton Asset Management PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
14 Jul 2022 21:44

TRADING UPDATES: Shield closer to Canada approval; Angle plans raise

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
30 Jun 2022 13:53

EARNINGS UPDATES: Kingswood revenue surges; Shield in loan deal

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

Read more
21 Mar 2022 14:38

TRADING UPDATES: Further progress at Blencowe and Rockfire mines

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Read more
21 Mar 2022 11:58

Shield's Canadian partner files new drug submission for Accrufer

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that KYE Pharmaceuticals has submitted a new drug submission to Health Canada, for the regulatory review and approval of the iron therapy 'Accrufer'.

Read more
17 Feb 2022 15:51

Shield Therapeutics revenue falls in line with expectations

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics reported total 2021 revenue of £1.5m in a trading update on Thursday, in line with market expectations.

Read more
17 Feb 2022 11:54

Shield Therapeutics shares fall as guides for sharp 2021 revenue drop

(Alliance News) - Shield Therapeutics PLC's shares tumbled on Thursday after a trading update revealed a substantial, but expected, fall in revenue.

Read more
5 Jan 2022 13:43

Shield Therapeutics enters Accrufer licensing deal in Canada

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics has entered into an exclusive licence agreement for 'Accrufer', it announced on Wednesday, with KYE Pharmaceuticals in Canada.

Read more
5 Jan 2022 10:35

Shield Therapeutics signs license agreement in Canada for lead product

Shield Therapeutics signs license agreement in Canada for lead product

Read more
16 Dec 2021 15:21

Shield shares surge on expansion of US coverage for Accrufer

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics updated the market on progress made on payer coverage of 'Accrufer' in the United States on Thursday.

Read more
16 Dec 2021 10:56

AIM WINNERS & LOSERS: Wressle boosts Europa Oil, Egdon and Union Jack

AIM WINNERS & LOSERS: Wressle boosts Europa Oil, Egdon and Union Jack

Read more
27 Sep 2021 14:26

Shield Therapeutics appoints chief medical officer

(Sharecast News) - Commercial-stage pharmaceutical company Shield Therapeutics announced on Monday that Dr Jose Menoyo is joining its senior executive team as vice-president and chief medical officer, with immediate effect.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.